AMANDA HASSLER: Open Payments
NPI 1700206877 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,785 in 138 payments from 18 companies in 2025. Trend: 2023 $2,767 · 2024 $2,038 · 2025 $2,785
Food & beverage: $2,686Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $503 |
| Janssen Biotech, Inc. | 16 | $367 |
| ABBVIE INC. | 17 | $312 |
| GENZYME CORPORATION | 13 | $231 |
| E.R. Squibb & Sons, L.L.C. | 6 | $191 |
| Arcutis Biotherapeutics, Inc. | 10 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $156 |
| Lilly USA, LLC | 8 | $150 |
| Galderma Laboratories, L.P. | 10 | $137 |
| Botanix SB Inc | 4 | $85 |
Products named: COSENTYX, TREMFYA, DUPIXENT, SKYRIZI, Sotyktu, Zoryve, NEMLUVIO, Winlevi.
Industry payments across TX — which companies pay providers there.
